WOOJUNG BIO, Inc. (KOSDAQ:215380)
2,360.00
0.00 (0.00%)
At close: Feb 19, 2026
WOOJUNG BIO Market Cap
WOOJUNG BIO has a market cap or net worth of 39.3 billion as of February 20, 2026. Its market cap has increased by 36.71% in one year.
Market Cap
39.30B
Enterprise Value
88.53B
Revenue
37.12B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,360.00
Market Cap Chart
Since April 20, 2017, WOOJUNG BIO's market cap has decreased from 44.42B to 39.30B, a decrease of -11.53%. That is a compound annual growth rate of -1.38%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 39.30B | 32.60% |
| Dec 30, 2025 | 29.64B | 3.59% |
| Dec 30, 2024 | 28.61B | 5.65% |
| Dec 28, 2023 | 27.08B | -29.98% |
| Dec 29, 2022 | 38.68B | -52.23% |
| Dec 30, 2021 | 80.97B | -29.00% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 20, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DreamCIS | 141.81B |
| LabGenomics | 125.09B |
| HLB bioStep | 106.69B |
| P&K Skin Research Center | 69.32B |
| C&R Research | 51.44B |
| DT&CRO CO. | 35.28B |
| SLS BIO | 26.89B |
| BioInfra | 22.38B |